ANLN protein as an endocrine treatment predictive factor

Details for Australian Patent Application No. 2009286183 (hide)

Owner Atlas Antibodies AB

Inventors Uhlen, Mathias; Ponten, Fredrik; Jirstrom, Karin

Agent Pizzeys

Pub. Number AU-A-2009286183

PCT Pub. Number WO2010/024776

Priority 08163428.9 01.09.08 EP; 61/093,410 01.09.08 US

Filing date 1 September 2009

Wipo publication date 4 March 2010

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/024776 Priority application(s): WO2010/024776

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009286189-Method and system for optimized LNG production

2009286182-New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis